<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: GlaxoSmithKline to share malaria research in hope of finding cure</title>
	<atom:link href="http://www.bioethicsinternational.org/blog/2010/01/25/glaxosmithkline-to-share-malaria-research-in-hope-of-finding-cure/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioethicsinternational.org/blog/2010/01/25/glaxosmithkline-to-share-malaria-research-in-hope-of-finding-cure/</link>
	<description>Because just enough isn&#039;t good enough</description>
	<lastBuildDate>Fri, 03 Feb 2012 23:23:55 -0700</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Colleen Lyons</title>
		<link>http://www.bioethicsinternational.org/blog/2010/01/25/glaxosmithkline-to-share-malaria-research-in-hope-of-finding-cure/comment-page-1/#comment-47157</link>
		<dc:creator>Colleen Lyons</dc:creator>
		<pubDate>Tue, 02 Feb 2010 17:40:33 +0000</pubDate>
		<guid isPermaLink="false">http://www.bioethicsinternational.org/blog/?p=1606#comment-47157</guid>
		<description>The Open Lab consortium- GSK, MMV and BIO Ventures for Global Health (BVGH) is an innovative business move that will help millions of people in developing nations.  A great example of profits and principle- they do not need to be mutually exclusive. 
Keep &#039;em coming.</description>
		<content:encoded><![CDATA[<p>The Open Lab consortium- GSK, MMV and BIO Ventures for Global Health (BVGH) is an innovative business move that will help millions of people in developing nations.  A great example of profits and principle- they do not need to be mutually exclusive.<br />
Keep &#8216;em coming.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

